How is the Protagonist Therapeutics Inc today?

The Protagonist Therapeutics Inc today is trading in the green, up by 0.20% at 45.91.

How has Protagonist Therapeutics Inc performed historically?

The Protagonist Therapeutics Inc is currently trading up 0.20% on an intraday basis in the past week the index rose 3.38%. The index has been up 18.48% in the past quarter and rose 44.78% in the past year. You can view this in the overview section.

What is Protagonist Therapeutics Inc Annual Revenue?

Protagonist Therapeutics Inc Annual Revenue rose 624.06%, in the last year to $434.43 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Protagonist Therapeutics Inc Annual Net Profit?

Protagonist Therapeutics Inc Annual Net Profit rose 448.54% in the last year to $275.19 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Protagonist Therapeutics Inc Price to Earning Ratio?

Protagonist Therapeutics Inc Price to Earning Ratio is 50.64, higher than its sector PE ratio of 4.04.

What is Protagonist Therapeutics Inc Stock Price?

Protagonist Therapeutics Inc Stock Price rose 44.78% and outperformed its sector by 33.24% in the past year.

What is Protagonist Therapeutics Inc Quarterly Revenue?

Protagonist Therapeutics Inc Quarterly Revenue fell 88.89% YoY to $28.32 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Protagonist Therapeutics Inc Quarterly Net profit?

Protagonist Therapeutics Inc Quarterly Net profit fell 105.62% YoY to $11.66 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Protagonist Therapeutics Inc Debt to Equity Ratio?

Protagonist Therapeutics Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Protagonist Therapeutics Inc Return on Equity(ROE)?

Protagonist Therapeutics Inc Return on Equity(ROE) for the last financial year was 54.39%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Protagonist Therapeutics Inc Mutual Fund Holding?

Protagonist Therapeutics Inc Mutual Fund Holding decreased by 6.39% in the last quarter to 50.57.

What is Protagonist Therapeutics Inc Promoter Share Holding?

Protagonist Therapeutics Inc Promoter Share Holding increased by 0.09% in the most recent quarter to 3.57%.

What is Protagonist Therapeutics Inc Institutional Holding?

Protagonist Therapeutics Inc Institutional Holding increased by 2.65% in the last quarter to 106.35.

Protagonist Therapeutics Inc XNAS: PTGX

Protagonist Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Protagonist Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Protagonist Therapeutics Inc
Rating: 2.031430625
Author: Trendlyne DVM scores

Expensive Rocket

about

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

45.91 0.09 (0.20%)

70.04% Gain from 52W Low

901.6K XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Protagonist Therapeutics Inc is on 02 Jun 2025 for the purpose of Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025 See details

Medium Financial Strength

38.9 / 100

Expensive Valuation

21.2 / 100

Technically Moderately Bullish

63.6 / 100

Expensive Rocket These stocks are a favourite among investors due to their bullish nature, good technical aspects but they have bad valuation and medium financials. View Similar Embed DVM

1Yr Price target upside is 50%

10 analysts

Protagonist Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Protagonist Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

70.04% Gain from 52W Low

SWOT Analysis

Protagonist Therapeutics Inc Live Price Chart

Protagonist Therapeutics Inc FAQ

How is Protagonist Therapeutics Inc today?

Protagonist Therapeutics Inc today is trading in the green, and is up by 0.20% at 45.91.

How has Protagonist Therapeutics Inc performed historically?

Protagonist Therapeutics Inc is currently trading up 0.20% on an intraday basis. In the past week the stock rose 3.38%. stock has been up 18.48% in the past quarter and rose 44.78% in the past year. You can view this in the overview section.